MRI-Guided Transurethral Ultrasound Ablation for Prostate Cancer
100
about 4.9 years
45–80
Male only
1 site in MN
What this study is about
This trial is testing whether MRI-guided transurethral ultrasound ablation (TULSA) can safely and effectively treat low to intermediate grade prostate cancer. TULSA is a minimally invasive procedure that uses ultrasound guided by MRI to destroy tumor cells in the prostate.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Questionnaire Administration
- 2.Undergo Biopsy
- 3.Undergo Bone Scan
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Change in quality of life, Metastasis-free survival, Multiparametric magnetic resonance imaging (mpMRI) Prostate Imaging and Reporting and Data System (PI-RADS) version 2 score for each visible lesion, Overall survival
biopsy, imaging, endoscopy
Oncology